首页> 外国专利> New tricyclic hydroxy carboxamides and tocolytic oxytocin receptor antagonists derived therefrom

New tricyclic hydroxy carboxamides and tocolytic oxytocin receptor antagonists derived therefrom

机译:新的三环羟基羧酰胺和由其衍生的宫缩催产素受体拮抗剂

摘要

"NEW HYDROXY TRICYCLIC CARBOXAMIDES AND TOCOLICY OTHOCOCINE RECEPTOR ANTAGONISTS FROM THE SAME". This invention provides novel tricyclic carboxamides that act as competitive oxytocin receptor antagonists, as well as methods of their manufacture, pharmaceutical compositions and methods for their use in treating, inhibiting, suppressing or preventing premature labor, dysmenorrhea and endometritis, labor suppression. of delivery within the period of pregnancy before cesarean delivery, and to facilitate antinatal transport to a medical facility. These compounds are also useful in enhancing fertility rates, enhancing survival rates and estrus synchronization in farm animals; and may be useful in preventing and treating central nervous system oxytocin system dysfunctions including obsessive compulsive disorder (OCD) and neuropsychiatric disorders.
机译:“相同的新型羟基三环羧酰胺和类固醇类球蛋白受体拮抗剂”。本发明提供了用作竞争性催产素受体拮抗剂的新型三环羧酰胺,及其制备方法,药物组合物及其在治疗,抑制,抑制或预防早产,痛经和子宫内​​膜炎,劳动抑制中的用途。在剖宫产之前在怀孕期间分娩,以利于将新生儿分娩至医疗机构。这些化合物还可用于提高农场动物的生育率,存活率和发情同步。可能对预防和治疗中枢神经系统催产素系统功能障碍(包括强迫症(OCD)和神经精神疾病)有用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号